Intervention Review

Quetiapine for schizophrenia

  1. Manit Srisurapanont1,*,
  2. Benchalak Maneeton1,
  3. Narong Maneeton1,
  4. Sudheer Lankappa2,
  5. Rahul Gandhi3

Editorial Group: Cochrane Schizophrenia Group

Published Online: 19 APR 2004

Assessed as up-to-date: 21 JAN 2004

DOI: 10.1002/14651858.CD000967.pub2

How to Cite

Srisurapanont M, Maneeton B, Maneeton N, Lankappa S, Gandhi R. Quetiapine for schizophrenia. Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No.: CD000967. DOI: 10.1002/14651858.CD000967.pub2.

Author Information

  1. 1

    Chiang Mai University, Department of Psychiatry, Faculty of Medicine, Chiang Mai, Thailand

  2. 2

    Nottinghamshire Healthcare NHS Trust, Psychiatric Outpatient, Nottingham, UK

  3. 3

    Nottinghamshire Healthcare NHS Trust, Millbrook Mental Health Unit, Sutton in Ashfield, UK

*Manit Srisurapanont, Department of Psychiatry, Faculty of Medicine, Chiang Mai University, P.O. Box 102, Amphur Muang, Chiang Mai, 50200, Thailand.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 19 APR 2004


  1. Current Version

    Quetiapine for schizophrenia

    Manit Srisurapanont, Benchalak Maneeton, Narong Maneeton, Sudheer Lankappa and Rahul Gandhi

    Version of Record online: 19 APR 2004 | DOI: 10.1002/14651858.CD000967.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Quetiapine for schizophrenia

    M Srisurapanont, C Disayavanish and K Taimkaew

    Version of Record online: 27 MAY 2000 | DOI: 10.1002/14651858.CD000967